The spinal cholinergic system and muscarinic acetylcholine receptors (mAChRs) 2 are important for the control of nociceptive transmission. For example, neurons and nerve terminals expressing choline acetyltransferase and acetylcholinesterase (enzymes for acetylcholine synthesis and degradation, respectively) are located in the spinal dorsal horn (1, 2). The superficial laminae contain the highest density of mAChRs in the spinal dorsal horn (3-5). Stimulation of mAChRs attenuates the responses of dorsal horn neurons to noxious stimuli (6), whereas blocking spinal mAChRs with atropine causes a large increase in pain sensitivity (7). Furthermore, spinally administered mAChR agonists or acetylcholinesterase inhibitors produce potent analgesia in both animals and humans (8 -11). Because agonists and antagonists that are highly selective for all mAChR subtypes are still lacking at this time, it is difficult to rely on pharmacological approaches alone to define which individual mAChR subtypes are involved in the regulation of synaptic and nociceptive transmission at the spinal level. Molecular cloning studies have revealed the existence of five molecularly distinct mAChR subtypes (M 1 -M 5 ) (12). The odd-numbered subtypes (M 1 , M 3 , and M 5 ) couple efficiently through the G q/11 class of G proteins to activate phospholipase C, which leads to inositol triphosphate-mediated calcium release from the endoplasmic reticulum and diacylglycerol-mediated activation of protein kinase C. The evennumbered mAChRs (M 2 and M 4 ) inhibit adenylyl cyclase activity through activation of the G i/o class of G proteins (12,13). In the spinal dorsal horn, M 2 is the major mAChR subtype, and the M 3 and M 4 subtypes represent only a fraction of the total mAChRs at the spinal level (11, 14 -16). Using mAChR subtype knock-out (KO) mice and an siRNA approach, we have shown that both the M 2 and M 4 subtypes mediate the analgesic effect of mAChR agonists in both rats and mice (11,14,17). In addition, using mAChR subtype-KO mice, we have demonstrated that the M 2 , M 3 , and M 4 subtypes are differentially involved in the control of GABAergic and glycinergic inhibitory synaptic transmission in the spinal dorsal horn (18,19). Glutamate is the predominant excitatory neurotransmitter involved in nociceptive transmission in the spinal dorsal horn. However, it remains unclear how individ-